Delivery Order 36F79722D0178-75A50323F80021
Award Date
8/17/23
Potential Completion Date
8/29/24
Potential Value
$8.7M
Awardee
Glaxosmithkline, LLC
Ultimate Awardee
Not listed
NAICS Category
325412 - Pharmaceutical Preparation Manufacturing
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Atlanta, GA 30331, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a definitive contract awarded by the Office of the Assistant Secretary for Preparedness and Response, a civilian federal agency, to Glaxosmithkline, LLC, a foreign-owned, for-profit pharmaceutical company. The contract is for the supply of RELENZA (ZANAMIVIR) ROTADISK, 5MG, an antiviral medication. The contract has a firm fixed price, with a ceiling value of $45,499,950.00, and a completion date of September 29, 2030. There is no set-aside designation for this contract. Glaxosmithkline...
This federal contract award to Glaxosmithkline, LLC, a pharmaceutical company, is for the drug RELENZA NDC # 00173-0681-22. The contract has a ceiling value of $249,900.00 and is a firm fixed price purchase order from the U.S. Department of Health and Human Services. The contract has an ultimate completion date of August 15, 2024 and was awarded on July 16, 2024. This award does not have a set-aside designation. Glaxosmithkline, a global pharmaceutical firm, frequently provides vaccines,...
This federal contract award to Glaxosmithkline, LLC (doing business as Glaxosmithkline) is for the purchase of 7,617 courses of the antiviral medication Zanamir (Relenza) at a firm fixed price of $17.37 per course, totaling $132,307.29. The award is from the Department of Homeland Security Countering Weapons of Mass Destruction program, with delivery required by October 31, 2018. The contract does not have a set-aside designation. Glaxosmithkline is a pharmaceutical company that provides a range...
This is a firm fixed price purchase order awarded by the Department of Veterans Affairs (VA) Veterans Health Administration to Glaxosmithkline, LLC, a foreign-owned pharmaceutical company, for the supply of RELENZA 5MG DISKHALER (NDC: 00173-0681-22). The contract has a potential value of $120,537.60 and a completion date of March 30, 2023. This award is not set-aside and appears to be part of the VA's broader efforts to procure pharmaceutical products and vaccines for its healthcare services....
This is a federal contract award to Glaxosmithkline, LLC by the U.S. Department of Homeland Security (DHS) for the acquisition of the antiviral medication Relenza to be included in the DHS antiviral stockpile. The contract has a ceiling value of $334,488 and is a firm fixed price delivery order. There is no set-aside designation for this award. Glaxosmithkline is a pharmaceutical company that provides a range of vaccines, antivirals, and other medical products to various U.S. government agencies...
This is a firm fixed price delivery order contract awarded by the Department of Homeland Security to Glaxosmithkline, LLC, a foreign-owned pharmaceutical company, to procure the antiviral medication Relenza. The contract has a potential value of $367,068.00 and does not have a set-aside designation. Glaxosmithkline has provided a range of pharmaceutical goods and services to various U.S. government agencies, including vaccines, antiviral medications, and other products to support disease...
The U.S. government agency Medical Supply Chain awarded a firm fixed price delivery order contract worth $229,284.00 to Glaxosmithkline, LLC, a pharmaceutical company, for the provision of zanamivir, an antiviral medication, with a period of performance ending on December 14, 2016. This contract was not set aside for any specific business type. Glaxosmithkline has previously been awarded other federal contracts and grants for the supply of various pharmaceutical products and services,...
This is a federal delivery order contract awarded by the Defense agency Medical Supply Chain to the prime contractor Glaxosmithkline, LLC for the supply of the antiviral medication zanamivir for inhalation. The contract has a ceiling value of $325,166.40 and was awarded on a firm fixed price basis with no set-aside designation. Glaxosmithkline has provided a range of pharmaceutical products and services to various U.S. government agencies through federal contracts and grants, including influenza...
This federal contract award was issued by the Defense Logistics Agency Troop Support Medical to Glaxosmithkline, LLC, doing business as Glaxosmithkline, a pharmaceutical company that provides vaccines, antiviral medications, and other pharmaceutical products to U.S. government agencies. The $331,245.90 firm fixed price delivery order is for the antiviral medication zanamivir. There is no set-aside designation for this award. Glaxosmithkline has held other federal contracts and grants,...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Glaxosmithkline, LLC, doing business as Glaxosmithkline. The contract is for the delivery of zanamivir, an antiviral medication, with a potential value of $361,912.00. The contract is a firm fixed price Delivery Order, with no set-aside designation. Glaxosmithkline is a pharmaceutical company that provides a range of products and services to U.S. government agencies, including vaccines, antiviral...